Continuing Education

Not All β-Receptors Appear the Same in Heart Failure: Emergence of β3-Agonists as a Therapeutic Option

June 28, 2022 Editor

Circulation: Heart Failure, Ahead of Print.

← Trends in Consumer Wearable Devices With Cardiac Sensors in a Primary Care Cohort
Hemodynamic Effects of Cyclic Guanosine Monophosphate-Dependent Signaling Through β3 Adrenoceptor Stimulation in Patients With Advanced Heart Failure: A Randomized Invasive Clinical Trial →